Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics

Publisher： Karger

E-ISSN： 1423-0143|27|4|259-266

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.27, Iss.4, 2004-09, pp. : 259-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characteristics, Cardiovascular Comorbidity and Medicines Management in Patients with Type 2 Diabetes and CKD: Results of the IRIDIEM Study

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 2, 2010-04 ,pp. : 119-128

Karger

Access to resources Recommend Favorite

2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial

By  

American Journal of Nephrology, Vol. 45, Iss. 1, 2016-11 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study

By  

Blood Purification, Vol. 41, Iss. 1-3, 2015-11 ,pp. : 87-93

Karger

Access to resources Recommend Favorite

Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study

By  

American Journal of Nephrology, Vol. 45, Iss. 5, 2017-05 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

Randomized Trial of Methylcobalamin and Folate Effects on Homocysteine in Hemodialysis Patients

By  

Nephron, Vol. 91, Iss. 1, 2002-05 ,pp. : 58-63

Karger

Access to resources Recommend Favorite